- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01708343
Paraspinal Stimulation in Treating MPS (DIMMST)
Paraspinal Stimulation Combined With Trigger Point Needling and Needle Rotation in Treating Myofascial Pain: Randomized Sham-controlled Clinical Trial
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: WOLNEI CAUMO, MD, PhD
- Phone Number: 55-51-3359-8083
- Email: caumo@cpovo.net
Study Contact Backup
- Name: CAUMO, MD., PhD
- Phone Number: 55-51-3359-8083
- Email: caumo@cpovo.net
Study Locations
-
-
RS
-
Porto Alegre, RS, Brazil, 90035-003
- Recruiting
- Hospital de Clínicas de Porto Alegre
-
Contact:
- José R Goldim, PhD
- Phone Number: 55 (51) 3359-8856
- Email: jrgoldim@gmail.com
-
Principal Investigator:
- Wolnei Caumo, MD., PhD
-
Sub-Investigator:
- IRACI LS TORRES, PhD
-
Sub-Investigator:
- FELIPE GREGNI, PhD
-
Porto Alegre, RS, Brazil, 90035-003
- Recruiting
- Hospital de Clínicas E Porto Alegre
-
Contact:
- JOSE GOLDIM, PhD
- Phone Number: 55 (51) 3359-8856.
- Email: jrgoldim@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- Myofascial pain syndrome (MPS) (defined as regional pain, normal neurologic examination, presence of TrPs, taut bands, tender points, and pain characterized as "dull," "achy," or "deep" were relevant to MPS diagnosis. Additionally, palpable nodules, pain that is exacerbated by stress, decreased range of motion, and ropiness in the muscle).
- Disability in the last three months: (defined if they had one or more these limitation in active and routine activities by MPS : (i) interference with work, (ii) enjoyable activities, (iii) responsibilities at home, (iv) relationships, (v) personal goals, (vi) thinking clearly, and problem solving, concentrating, or remembering during the last three months).
- Women
- Age: 19 to 50 years
Exclusion criteria
Rheumatoid arthritis
Fibromyalgia
Previous surgery on the affected areas
Prior experience with acupuncture
Primary radiculopathy
Current use of psychotropic drugs (ilicits
) Habitual use of anti-inflammatory steroids.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Placebo-sham
Placebo-sham twice a week during four weeks
|
Other Names:
|
Active Comparator: Lidocaine injection
Lidocaine 0.2-0.5 mL of 1% injected each time into the trigger point.
Twice a week during four weeks
|
Other Names:
|
Experimental: DIMMST
DIMMST include the combination of trigger point deep dry needling (TrP-DDN) is combined with paraspinal deep intramuscular stimulation (PDIMS) and needle rotation (NR). Twice a week during four weeks |
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain severity
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
a) The intensity of pain was measured by a 10-cm VAS [30].
VAS scores ranged from no pain (zero) to the worst possible pain (10 cm).
|
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Pain threshold
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Pain pressure threshold (PPT)
|
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep quality - how did you feel when you woke up
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS: In general, how did you feel when you woke up? |
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality - compared to your habitual sleep
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS: Assess the sleep quality of the previous night compared to your habitual sleep? |
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality -last night
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS: How well did you sleep last night? |
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical and mental Health
Time Frame: Before to begin treatment and after end treatment
|
Health-related quality of life, assessed at baseline and the end of treatment sessions, was measured with the SF-12 Summary Scales
|
Before to begin treatment and after end treatment
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MPS-DIMS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical Study - RCT
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
CelgeneCompletedClinical Pharmacology, Healthy Volunteer StudyUnited States
-
CelgeneCompletedClinical Pharmacology, Healthy Male Volunteer StudyUnited States
-
Boston Scientific CorporationICON plcCompletedPost Market Surveillance Study Following Clinical RoutineGermany, Finland
-
Perseverance Research Center, LLCHDCCompletedStudy Subjects Currently Enrolled in a Clinical Research TrialUnited States
-
CelgeneCompletedClinical Pharmacology, Healthy Volunteer StudyUnited States
-
Centre Hospitalier Universitaire, AmiensCHU de Reims; University Hospital, Montpellier; Saint Antoine University Hospital and other collaboratorsRecruitingArtificial Intelligence | Iatrogenesis | Clinical Vignettes | Diagnostic Performance Study | Medical Information SearchFrance
-
PATHBill and Melinda Gates Foundation; UNITAIDRecruitingFocus of Study: Accurate Clinical Measurement and DiagnosisKenya
-
University of Sao Paulo General HospitalUnknownThere Are no Specific Conditions Under Study | This Study Evaluates the Clinical Decision-Making Associated With Intensive Care Units Rationing
-
Imperial College LondonJoint Replacement Instrumented Orthopaedics LtdRecruitingFocus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip StemUnited Kingdom